Delivering the Right Patients at the Right Time for NASH Clinical Trials

This video showcases the capabilities of AES in the field of NAFLD & NASH, and how AES is advancing clinical development in NASH and NAFLD by simultaneously solving the challenges of site selection and patient enrollment.

Let us help you find the right patients for the right trial at the right time

As the industry’s high-performance trial delivery company, AES combines exceptional patient access and a consolidated global infrastructure of highly standardized sites along with greater budget certainty.

If you are interested in speaking with us, fill in the form and we’ll get back to you shortly.

Patient access

Our proprietary databases of more than 100 million households and 20 million pre-screened study candidates offer access to the 95% of the population not available within a normal site’s database or marketing abilities. We make it possible for sponsors to enroll 30%-80% of the patients they’ll need for their trial.

Site conduct

With a global site infrastructure of over 150 standardized sites across 16 countries, AES helps you achieve more from a smaller number of sites, improving trial productivity and often reducing cost. Our centralized command and control of site conduct allows for consistent operations and quality worldwide.

Performance pricing

Our fee structure is based on delivery of what you need…randomized patients to your trial. Our Global pay-for-performance price guarantee is unconventional in the industry but is a product of the high confidence level we have in the results we can produce.